Larimar Therapeutics
Price & Volume
Stats
See moreOpen | $3.68 |
Previous Close | $3.72 |
Day Range | $3.59-$3.76 |
52W Range | $2.71-$6.42 |
Market Cap | $444.6M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.12 |
News
See moreYahoo Finance • 18 days ago
Larimar To Host Investor Event On Nomlabofusp Program On Monday, Stock Up
Yahoo Finance • 18 days ago
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
Yahoo Finance • 29 days ago
Exploring 3 High Growth Tech Stocks in US Market
Yahoo Finance • 5 months ago
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
About
CEO | Dr. Carole S. Ben-Maimon M.D. |
CFO | Mr. Michael Celano CPA |
Address | Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 71 |